Myriad Genetics Files 8-K: Operations, Personnel & Financials
Ticker: MYGN · Form: 8-K · Filed: Feb 24, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, personnel, financials, regulation-fd
Related Tickers: MYGN
TL;DR
MYGN filed an 8-K covering financials, exec changes, and Reg FD. Stay tuned for details.
AI Summary
Myriad Genetics, Inc. filed an 8-K on February 24, 2025, reporting on its results of operations and financial condition. The filing also disclosed the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. Additionally, it included a Regulation FD disclosure and financial statements and exhibits.
Why It Matters
This 8-K filing provides crucial updates on Myriad Genetics' operational and financial status, as well as significant changes in its leadership and executive compensation, which could impact investor decisions.
Risk Assessment
Risk Level: medium — The filing covers a range of items including financial results and executive changes, which can introduce uncertainty and potential volatility.
Key Players & Entities
- MYRIAD GENETICS INC (company) — Registrant
- February 24, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Salt Lake City, Utah (location) — Principal Executive Offices
- 801-584-3600 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported by Myriad Genetics in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific financial figures within the provided text.
Were there any significant executive departures or appointments announced?
Yes, the filing explicitly mentions 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers'.
What is the significance of the 'Regulation FD Disclosure' item?
This indicates that Myriad Genetics is making public disclosures to prevent selective disclosure of material non-public information.
When was this 8-K filing submitted to the SEC?
The filing was submitted on February 24, 2025.
What is Myriad Genetics' primary business as indicated by its SIC code?
Myriad Genetics' Standard Industrial Classification (SIC) code is 2835, which relates to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding MYRIAD GENETICS INC (MYGN).